Proton Beam Therapy Versus Photon Radiotherapy for Pediatric Neuroblastoma: A Systematic Review and Meta‐Analysis ( TRP ‐2025 Neuroblastoma)
Cancer Medicine · 2026-03 · 15 (3)
DOI: 10.1002/cam4.71701 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cancer Medicine, online erschienen am 09.03.2026. Verfasst von Hazuki Nitta und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Tsukuba, Ibaraki, Japan. Hauptthemen laut MEDLINE: Proton Therapy, Neuroblastoma, Photons. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives Radiotherapy (RT) is a standard component of treatment for high‐risk pediatric neuroblastoma. Proton beam therapy (PBT) offers dosimetric advantages over photon radiotherapy (XRT), but comparative clinical data remain limited.
Methods
As part of the review project at our facility, we conducted a systematic review and meta‐analysis comparing survival outcomes between PBT and XRT. PubMed was searched for studies published between 1990 and 2022. Eligible studies included those for pediatric patients with neuroblastoma receiving curative‐intent RT and reporting overall survival (OS) or progression‐free survival (PFS). A random‐effects meta‐analysis and meta‐regression were performed.
Results
Eighteen studies (6 PBT, 12 XRT) were included. The 1‐ and 2‐year OS rates were 97.2% and 92.0% for PBT, and 89.1% and 81.3% for XRT. Corresponding PFS rates were 96.1% and 86.1% for PBT, and 78.6% and 64.5% for XRT. Meta‐regression identified treatment modality as a significant factor for 2‐year OS and PFS. However, variability in patient background and treatment protocols may have influenced the results. Limited toxicity data suggested low rates of grade ≥ 3 acute adverse events in both groups.
Conclusions
PBT gave survival outcomes that were at least comparable to XRT in pediatric neuroblastoma. Given its potential to reduce long‐term toxicity, PBT may be a reasonable alternative in selected cases. Further prospective studies are needed to validate these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, University of Tsukuba, Ibaraki, Japan.
- Department of Biostatistics, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
- Department of Radiation Oncology, Tsukuba Medical Center Hospital, Ibaraki, Japan.
- Department of Pediatrics, University of Tsukuba Hospital, Ibaraki, Japan.
- Department of Child Health, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
- Department of Pediatric Radiation Therapy Center/Pediatric Proton Beam Therapy Center, Hebei Yizhou Cancer Hospital, China.
ORCID-Profile: Masashi Mizumoto, Kazushi Maruo, Yinuo Li, Hiroko Fukushima
Zitieren
APA
Nitta, H., Mizumoto, M., Maruo, K., Oshiro, Y., Li, Y., Inaba, M., Saito, T., Hosaka, S., Iizumi, T., Fukushima, H., Suzuki, R., Shimizu, S., Nakai, K., & Sakurai, H. (2026). Proton Beam Therapy Versus Photon Radiotherapy for Pediatric Neuroblastoma: A Systematic Review and Meta‐Analysis ( TRP ‐2025 Neuroblastoma). Cancer Medicine, 15(3). https://doi.org/10.1002/cam4.71701
Vancouver
Nitta H, Mizumoto M, Maruo K, Oshiro Y, Li Y, Inaba M, et al. Proton Beam Therapy Versus Photon Radiotherapy for Pediatric Neuroblastoma: A Systematic Review and Meta‐Analysis ( TRP ‐2025 Neuroblastoma). Cancer Medicine. 2026;15(3). doi:10.1002/cam4.71701
BibTeX
@article{Nitta2026,
author = {Nitta, Hazuki and Mizumoto, Masashi and Maruo, Kazushi and Oshiro, Yoshiko and Li, Yinuo and Inaba, Masako and Saito, Takashi and Hosaka, Sho and Iizumi, Takashi and Fukushima, Hiroko and Suzuki, Ryoko and Shimizu, Shosei and Nakai, Kei and Sakurai, Hideyuki},
title = {Proton Beam Therapy Versus Photon Radiotherapy for Pediatric Neuroblastoma: A Systematic Review and Meta‐Analysis ( TRP ‐2025 Neuroblastoma)},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {3},
doi = {10.1002/cam4.71701}
}
EUVIMED